Citigroup’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

Citigroup’s Portfolio BITI Stock Details BITI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,407	Closed	-$143K	–	7791
2016 Q1	$143K	Buy	5,407 +407	+8%	+$9.48K	﹤0.01%	5401
2015 Q4	$71K	Buy	+5,000	New	+$70K	﹤0.01%	5660
2015 Q3	–	Sell	-10	Closed	–	–	8115
2015 Q2	$0	Buy	+10	New	+$209	﹤0.01%	7992

Citigroup's BITI Position: Q2 2016 in Review

Citigroup sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q2 2016, closing a stake of 5,407 shares — an estimated $143K sold.

Citigroup first reported a position in BITI in Q2 2015 and held it in 3 quarters. The position peaked at $143K in Q1 2016. 0 funds tracked by Wall St. Rank hold BITI as of Q2 2016.

Citigroup reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q2 2016 after selling out during the quarter.
Citigroup sold 5,407 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q2 2016, an estimated $143K.
Citigroup first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q2 2015 and held it in 3 quarters.
Citigroup's BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $143K in Q1 2016.
0 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.